Esophageal Adenocarcinoma — Trials

Esophageal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 45
Ph III recruiting: 4
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03366012	Rapid Assessment of Esophageal Adenocarcinoma Risk Test(REACT)	terminated	N/A	51	Columbia UniversityOTHER	1	Nov 8, 2024	clinicaltrials
NCT03240679	Endoscopic Mucosal Resection and Cellular Matrix	terminated	N/A	3	Mayo ClinicOTHER	1	Feb 6, 2023	clinicaltrials